MedPath

Temporomandibular Dysfunction in Patients With Tinnitus: Assessment and Treatment

Not Applicable
Completed
Conditions
Tinnitus, Subjective
Registration Number
NCT03209297
Lead Sponsor
Universiteit Antwerpen
Brief Summary

TMD treatment, based on state of the art knowledge derived from clinical studies will be applied in patients with tinnitus and TMD. When this approach proves to be useful for the treatment of tinnitus, it offers a new therapeutic option for patients with tinnitus. To understand how TMD treatment works for patients with tinnitus, we will analyse mediating factors, i.e. factors that contribute to the therapeutic effect. To help clinicians in their clinical process we will identify prognostic indicators, i.e. factors that predict a positive or negative outcome of TMD treatment. This can provide a helpful tool in clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Patients will be included when suffering from somatic tinnitus, attributed to TMD, which has been stable for at least 3 months.
  • Tinnitus Functional Index score between 25 and 90
Exclusion Criteria
  • clear otological or neurological causes of the tinnitus such as Menière's disease, severe depression (diagnosed by a psychologist), progressive middle ear pathology, intracranial pathology
  • traumatic cervical spine or temporomandibular injury in the past 6 months
  • tumours
  • previous surgery in the orofacial area
  • in case physical therapy treatment directed to the orofacial area is contra-indicated
  • if the patient received TMD treatment in the past 2 months
  • drug intake that can affect the outcome measures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Tinnitus QuestionnaireBaseline, 9 weeks, 18 weeks, 27 weeks

Questionnaire to measure the change in tinnitus related distress

Secondary Outcome Measures
NameTimeMethod
Specific anamnestic questionsBaseline

pre-defined list of questions on duration of the tinnitus complaints, modulation, bruxism,...

Hyperacusis QuestionnaireBaseline

Questionnaire to measure the presence of hyperacusis

Visual analogue scale for tinnitus loudnessBaseline, 9 weeks, 18 weeks, 27 weeks

Scale to measure the change in average tinnitus loudness

Tinnitus AnalysisBaseline

analysis of the tinnitus type, pitch and loudness

Speech in noise testBaseline, 9 weeks, 18 weeks, 27 weeks

analysis of the change in understanding spoken words in a noisy situation

Tinnitus Functional IndexBaseline, 9 weeks, 18 weeks, 27 weeks

Questionnaire to measure the change in tinnitus severity

Hospital anxiety and depression scaleBaseline

Questionnaire to measure the presence of anxiety and/or depression

Pain on palpation of masseter, temporalis and temporomandibular jointBaseline, 9 weeks, 18 weeks, 27 weeks

change in recognisable pain on palpation, measured on numerical rating scale

Auditory evoked potentials measurementBaseline, 18 weeks

change in EEG during listening tasks

TMD pain screenerBaseline, 9 weeks, 18 weeks, 27 weeks

Questionnaire to assess the presence of and change in temporomandibular disorders(TMD) symptoms

Dynamic investigation of the temporomandibular jointBaseline, 9 weeks, 18 weeks, 27 weeks

evaluation of change in isotonic contraction of jaw muscles

Mouth openingBaseline, 9 weeks, 18 weeks, 27 weeks

change in mouth opening measured in cm with a ruler

Static investigation of the temporomandibular jointBaseline, 9 weeks, 18 weeks, 27 weeks

evaluation of change in isometric contraction of jaw muscles

Pain pressure thresholdBaseline, 9 weeks, 18 weeks, 27 weeks

measurement of change in pain pressure thresholds on masseter, temporalis, temporomandibular joint, sternocleidomastoideus, tibialis anterior

Pure tone audiometryBaseline

evaluation of possible hearing problems

Trial Locations

Locations (1)

Universitair ziekenhuis Antwerpen

🇧🇪

Edegem, Antwerpen, Belgium

© Copyright 2025. All Rights Reserved by MedPath